DE3764051D1 - Verfahren zur herstellung von alpha-n-((hypoxanthin-9-yl)-pentyloxycarbonyl)-arginin. - Google Patents

Verfahren zur herstellung von alpha-n-((hypoxanthin-9-yl)-pentyloxycarbonyl)-arginin.

Info

Publication number
DE3764051D1
DE3764051D1 DE8787113168T DE3764051T DE3764051D1 DE 3764051 D1 DE3764051 D1 DE 3764051D1 DE 8787113168 T DE8787113168 T DE 8787113168T DE 3764051 T DE3764051 T DE 3764051T DE 3764051 D1 DE3764051 D1 DE 3764051D1
Authority
DE
Germany
Prior art keywords
hypoxanthin
pentyloxycarbonyl
arginine
producing alpha
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787113168T
Other languages
German (de)
English (en)
Inventor
Riccardo Stradi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE3764051D1 publication Critical patent/DE3764051D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE8787113168T 1986-09-17 1987-09-09 Verfahren zur herstellung von alpha-n-((hypoxanthin-9-yl)-pentyloxycarbonyl)-arginin. Expired - Fee Related DE3764051D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8621734A IT1213495B (it) 1986-09-17 1986-09-17 Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina

Publications (1)

Publication Number Publication Date
DE3764051D1 true DE3764051D1 (de) 1990-09-06

Family

ID=11186113

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787113168T Expired - Fee Related DE3764051D1 (de) 1986-09-17 1987-09-09 Verfahren zur herstellung von alpha-n-((hypoxanthin-9-yl)-pentyloxycarbonyl)-arginin.

Country Status (16)

Country Link
EP (1) EP0260588B1 (US07847105-20101207-C00016.png)
JP (1) JPS6388184A (US07847105-20101207-C00016.png)
KR (1) KR950008971B1 (US07847105-20101207-C00016.png)
AR (1) AR242576A1 (US07847105-20101207-C00016.png)
AT (1) ATE55130T1 (US07847105-20101207-C00016.png)
AU (1) AU593136B2 (US07847105-20101207-C00016.png)
CA (1) CA1276148C (US07847105-20101207-C00016.png)
DE (1) DE3764051D1 (US07847105-20101207-C00016.png)
DK (1) DK168570B1 (US07847105-20101207-C00016.png)
ES (1) ES2017485B3 (US07847105-20101207-C00016.png)
GR (1) GR3000796T3 (US07847105-20101207-C00016.png)
IL (1) IL83863A0 (US07847105-20101207-C00016.png)
IN (1) IN165609B (US07847105-20101207-C00016.png)
IT (1) IT1213495B (US07847105-20101207-C00016.png)
PH (1) PH25318A (US07847105-20101207-C00016.png)
ZA (1) ZA876961B (US07847105-20101207-C00016.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241452B (it) * 1990-06-28 1994-01-17 Sigma Tau Ind Farmaceuti Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
IT1244501B (it) * 1991-03-22 1994-07-15 Sigma Tau Ind Farmaceuti Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
US6110923A (en) * 1994-06-22 2000-08-29 Biochem Pharma Inc. Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
CA2320900C (en) 1998-03-19 2009-10-27 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
MX342120B (es) 2010-07-09 2016-09-14 William Owen Wilkison Combinación de sistema de liberación prolongada/inmediata para productos farmacéuticos de vida media corta como el remogliflozin.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives

Also Published As

Publication number Publication date
PH25318A (en) 1991-04-30
AU7847187A (en) 1988-03-24
AR242576A1 (es) 1993-04-30
IN165609B (US07847105-20101207-C00016.png) 1989-11-25
EP0260588B1 (en) 1990-08-01
DK489087A (da) 1988-03-18
GR3000796T3 (en) 1991-10-10
IL83863A0 (en) 1988-02-29
CA1276148C (en) 1990-11-13
ATE55130T1 (de) 1990-08-15
IT8621734A0 (it) 1986-09-17
JPS6388184A (ja) 1988-04-19
IT1213495B (it) 1989-12-20
KR950008971B1 (ko) 1995-08-10
KR880003944A (ko) 1988-06-01
EP0260588A1 (en) 1988-03-23
DK168570B1 (da) 1994-04-25
ES2017485B3 (es) 1991-02-16
DK489087D0 (da) 1987-09-17
AU593136B2 (en) 1990-02-01
ZA876961B (en) 1988-05-25

Similar Documents

Publication Publication Date Title
DE3767431D1 (de) Verfahren zur herstellung von halbleiterbauelementen.
DE3761744D1 (de) Verfahren zur herstellung von granulaten.
DE3766300D1 (de) Verfahren zur herstellung von imidazopyridinen.
DE3765009D1 (de) Verfahren zur herstellung von 4-acetoxy-3-hydroxyaethyl-azetidin-2-one-derivaten.
DE3762745D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylthiazol.
DE3765983D1 (de) Verfahren zur herstellung von caprolactam.
DE3766216D1 (de) Verfahren zur herstellung von laminaten.
DE3763558D1 (de) Verfahren zur herstellung von 2-chlor-5-chlormethylpyridin.
DE3777987D1 (de) Verfahren zur herstellung von 2-beta-substituierten methylpenicillin-derivaten.
DE3784151D1 (de) Verfahren zur herstellung von alkylhalosilanen.
DE3773889D1 (de) Verfahren zur herstellung von merkaptomethylphenolen.
DE3764421D1 (de) Verfahren zur herstellung von tertiaeren olefinen.
DE3880201D1 (de) Verfahren zur herstellung von organopolysiloxanen.
DE3780704D1 (de) Verfahren zur herstellung von n-acyltetrahydroisochinoline.
DE3785530D1 (de) Verfahren zur herstellung von l-arginin.
DE3776464D1 (de) Verfahren zur herstellung von maleimiden.
DE3768784D1 (de) Verfahren zur herstellung von caprolactam.
DE3766910D1 (de) Verfahren zur herstellung von dihydrocyclocitral.
DE3769076D1 (de) Verfahren zur herstellung von fluorbenzaldehyden.
DE3761539D1 (de) Verfahren zur herstellung von verbundteilen.
DE3765090D1 (de) Verfahren zur herstellung von 2-acylfuranderivaten.
DE3764051D1 (de) Verfahren zur herstellung von alpha-n-((hypoxanthin-9-yl)-pentyloxycarbonyl)-arginin.
DE3777475D1 (de) Verfahren zur herstellung von polyphenylen-ether-polyester-copolymeren.
DE3769263D1 (de) Verfahren zur herstellung von bromfluoroethylhypofluorit.
ATA304487A (de) Verfahren zur herstellung von 9alpha-hydroxy-4-androsten-3,17-dion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee